{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:12:11Z","timestamp":1792858331871,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2014,6,25]],"date-time":"2014-06-25T00:00:00Z","timestamp":1403654400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1245\/s10434-014-3859-3","type":"journal-article","created":{"date-parts":[[2014,6,24]],"date-time":"2014-06-24T16:14:26Z","timestamp":1403626466000},"page":"4139-4143","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["An Investigation into the Serum Thioredoxin, Superoxide Dismutase, Malondialdehyde, and Advanced Oxidation Protein Products in Patients with Breast Cancer"],"prefix":"10.1245","volume":"21","author":[{"given":"Nedret","family":"Kilic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mine","family":"Yavuz Taslipinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yildiz","family":"Guney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ercument","family":"Tekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhan","family":"Onuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,25]]},"reference":[{"key":"3859_CR1","unstructured":"Latest world cancer statistics. The online GLOBOCAN (2012). http:\/\/globocan.iarc.fr\/ ."},{"key":"3859_CR2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.mrfmmm.2011.02.015","volume":"711","author":"D Ziech","year":"2011","unstructured":"Ziech D, Franco R, Pappa A, Panayiotidis MI. Reactive oxygen species (ROS)-induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res. 2011;711:167\u201373.","journal-title":"Mutat Res."},{"key":"3859_CR3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mrfmmm.2011.06.009","volume":"730","author":"J Prescott","year":"2012","unstructured":"Prescott J, Wentzensen IM, Savage SA, De Vivo I. Epidemiologic evidence for a role of telomere dysfunction in cancer etiology. Mutat Res. 2012;730:75\u201384.","journal-title":"Mutat Res."},{"key":"3859_CR4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.critrevonc.2011.01.004","volume":"80","author":"L Vera-Ramirez","year":"2011","unstructured":"Vera-Ramirez L, Sanchez-Rovira P, Ramirez-Tortosa MC, et al. Free radicals in breast carcinogenesis, breast cancer progression and cancer stem cells. Biological bases to develop oxidative-based therapies. Crit Rev Oncol Hematol. 2011;80:347\u201368.","journal-title":"Crit Rev Oncol Hematol."},{"key":"3859_CR5","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.semcdb.2012.04.003","volume":"23","author":"TT Huang","year":"2012","unstructured":"Huang TT, Zou Y, Corniola R. Oxidative stress and adult neurogenesis\u2014effects of radiation and superoxide dismutase deficiency. Semin Cell Dev Biol. 2012;23:738\u201344.","journal-title":"Semin Cell Dev Biol."},{"key":"3859_CR6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev.pharmtox.41.1.261","volume":"41","author":"G Powis","year":"2001","unstructured":"Powis G, Montfort WR. Properties and biological activities of thioredoxins. Ann Rev Pharmacol Toxicol. 2001;41:261\u201395.","journal-title":"Ann Rev Pharmacol Toxicol."},{"key":"3859_CR7","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0167-4781(94)90180-5","volume":"1218","author":"PY Gasdaska","year":"1994","unstructured":"Gasdaska PY, Oblong JE, Cotgreave IA, Powis G. The predicted amino acid sequence of human thioredoxin is identical to that of the autocrine growth factor human adult T-cell derived factor (ADF): thioredoxin mRNA is elevated in some human tumors. Biochim Biophys Acta. 1994;1218:292\u20136.","journal-title":"Biochim Biophys Acta."},{"key":"3859_CR8","doi-asserted-by":"crossref","first-page":"6628","DOI":"10.1021\/bi00269a003","volume":"21","author":"M Luthman","year":"1982","unstructured":"Luthman M, Holgren A. Rat liver thioredoxin and thioredoxin reductase: purification and characterization. Biochemistry. 1982;21:6628\u201333.","journal-title":"Biochemistry"},{"key":"3859_CR9","first-page":"539","volume":"6","author":"G Powis","year":"1994","unstructured":"Powis G, Oblong JE, Gasdaska PY, Berggren M, Hill S, Kirkpatrick DL. The thioredoxin\/thioredoxin reductase redox system and control of cell growth. Oncol Res. 1994;6:539\u201344.","journal-title":"Oncol Res."},{"issue":"9","key":"3859_CR10","doi-asserted-by":"crossref","first-page":"e71427","DOI":"10.1371\/journal.pone.0071427","volume":"8","author":"MH Yoo","year":"2013","unstructured":"Yoo MH, Carlson BA, Gladyshev VN, Hatfield DL. Abrogated thioredoxin system causes increased sensitivity to TNF-\u03b1-induced apoptosis via enrichment of p-ERK 1\/2 in the nucleus. PLOS One. 2013;8(9):e71427. doi: 10.1371\/journal.pone.0071427 .","journal-title":"PLOS One"},{"key":"3859_CR11","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0891-5849(01)00724-9","volume":"31","author":"J Nordberg","year":"2001","unstructured":"Nordberg J, Arner ES. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med. 2001;31:1287\u201312.","journal-title":"Free Radic Biol Med."},{"key":"3859_CR12","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0002-9378(79)90708-7","volume":"135","author":"T Yoshioka","year":"1979","unstructured":"Yoshioka T, Kawada K, Shimada T, Mori M. Lipid peroxidation in maternal and cord blood protective mechanism against activated-oxygen toxicity in the blood. Am J Obstet Gynecol. 1979;135:372\u20136.","journal-title":"Am J Obstet Gynecol."},{"key":"3859_CR13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/clinchem\/34.3.497","volume":"34","author":"Y Sun","year":"1988","unstructured":"Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34:497\u2013500.","journal-title":"Clin Chem."},{"key":"3859_CR14","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ki.1996.186","volume":"49","author":"V Witko-Sarsat","year":"1996","unstructured":"Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996;49:1304\u201313.","journal-title":"Kidney Int"},{"key":"3859_CR15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/0192623309356453","volume":"38","author":"JE Klaunig","year":"2010","unstructured":"Klaunig JE, Kamendulis LM, Hocevar BA. Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol. 2010;38:96\u2013109.","journal-title":"Toxicol Pathol."},{"key":"3859_CR16","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1096\/fj.02-0752rev","volume":"10","author":"MS Cooke","year":"2003","unstructured":"Cooke MS, Evans MD, Dizdaro\u011flu M, Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 2003;10:1195\u2013214.","journal-title":"FASEB J."},{"key":"3859_CR17","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.7314\/APJCP.2012.13.12.6295","volume":"13","author":"RK Gupta","year":"2012","unstructured":"Gupta RK, Patel AK, Kumari R, Chugh S, Shrivastav C, Mehra S, Sharma AN. Interactions between oxidative stress, lipid profile and antioxidants in breast cancer: a case control study. Asian Pac J Cancer Prev. 2012;13:6295\u20138.","journal-title":"Asian Pac J Cancer Prev."},{"key":"3859_CR18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1365-2710.2001.00334.x","volume":"26","author":"A Gonenc","year":"2001","unstructured":"Gonenc A, Ozkan Y, Torun M, Simsek B. Plasma malondialdehyde (MDA) levels in breast and lung cancer patients. J Clin Pharm Ther. 2001;26:141\u20134.","journal-title":"J Clin Pharm Ther."},{"key":"3859_CR19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cccn.2005.05.002","volume":"361","author":"CC Yeh","year":"2005","unstructured":"Yeh CC, Hou MF, Tsai SM, et al. Superoxide anion radical, lipid peroxides and antioxidant status in the blood of patients with breast cancer. Clin Chim Acta. 2005;361:104\u201311.","journal-title":"Clin Chim Acta."},{"key":"3859_CR20","first-page":"640","volume":"49","author":"CP Rajneesh","year":"2008","unstructured":"Rajneesh CP, Manimaran A, Sasikala KR, Adaikappan P. Lipid peroxidation and antioxidant status in patients with breast cancer. Singapore Med J. 2008;49:640\u20133.","journal-title":"Singapore Med J."},{"key":"3859_CR21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/cbf.980","volume":"20","author":"FM Polat","year":"2002","unstructured":"Polat FM, Taysi S, Gul M. Oxidant\/antioxidant status in blood of patients with malignant breast tumor and benign breast disease. Cell Biochem Funct. 2002;20:327\u201331.","journal-title":"Cell Biochem Funct."},{"key":"3859_CR22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1023\/A:1006357330486","volume":"59","author":"G Ray","year":"2000","unstructured":"Ray G, Batras S, Shukla NK. Lipid peroxidation, free radical production and antioxidant status in tissues of breast cancer. Breast Cancer Res Treat. 2000;59:163\u201370.","journal-title":"Breast Cancer Res Treat."},{"key":"3859_CR23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0009-9120(00)00067-9","volume":"33","author":"P Oytun","year":"2000","unstructured":"Oytun P, Ozay O, Mine EI. Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients. Clin Biochem. 2000;33:279\u201384.","journal-title":"Clin Biochem."},{"key":"3859_CR24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbadis.2004.02.008","volume":"1689","author":"C Capeillere-Blandin","year":"2004","unstructured":"Capeillere-Blandin C, Gausson V, Descamps-Latscha B, Witko-Sarsat V. Biochemical and spectrophotometric significance of advanced oxidized protein products. Biochim Biophys Acta. 2004;1689:91\u2013102.","journal-title":"Biochim Biophys Acta."},{"key":"3859_CR25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0021-9150(01)00706-7","volume":"162","author":"H Kaneda","year":"2002","unstructured":"Kaneda H, Taguchi J, Ogasawara K, Aizawa T, Ohno M. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis. 2002;162:221\u20135.","journal-title":"Atherosclerosis."},{"key":"3859_CR26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5507\/bp.2004.023","volume":"148","author":"M Lazarova","year":"2004","unstructured":"Lazarova M, Stejskal D, Lacnak B, et al. The antioxidant acetylcysteine reduces oxidative stress by decreasing level of AOPPs. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2004;148:131\u20133.","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub."},{"key":"3859_CR27","first-page":"2616","volume":"14","author":"F Kosova","year":"2007","unstructured":"Kosova F, \u00c7etin B, Ak\u0131nc\u0131 M, et al. Advanced oxidation protein products, ferrous oxidation in xylenol orange, and malondialdehyde levels in thyroid cancer. Endocrine Tumors. 2007;14:2616\u201320.","journal-title":"Endocrine Tumors."},{"key":"3859_CR28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1756-0500-7-7","volume":"7","author":"BJ Park","year":"2014","unstructured":"Park BJ, Cha MK, Kim IH. Thioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity of breast cancer diagnoses. BMC Res Notes. 2014;7:7. doi: 10.1186\/1756-0500-7-7 .","journal-title":"BMC Res Notes."},{"key":"3859_CR29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0165-2478(00)00284-4","volume":"75","author":"M Ueno","year":"2000","unstructured":"Ueno M, Matsutani Y, Nakamura H, et al. Possible association of thioredoxin and p53 in breast cancer. Immunol Lett. 2000;75:15\u201320.","journal-title":"Immunol Lett."},{"key":"3859_CR30","first-page":"2425","volume":"23","author":"DT Lincoln","year":"2003","unstructured":"Lincoln DT, Ali Amadi LM, Tonissen KF, Clarke FM. The thioredoxin\u2013thioredoxin reductase system: over-expression in human cancer. Anticancer Res. 2003;23:2425\u201333.","journal-title":"Anticancer Res."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-3859-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-014-3859-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-3859-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T09:29:34Z","timestamp":1598002174000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-014-3859-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,25]]},"references-count":30,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3859"],"URL":"https:\/\/doi.org\/10.1245\/s10434-014-3859-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,25]]}}}